Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series.
Jessica AtiehJordan SackRichard ThomasOsama E RahmaMichael CamilleriShilpa GroverPublished in: Digestive diseases and sciences (2020)
This report documents gastroparesis as a potential adverse effect of ICI. Further studies should explore the potential for ICI therapy to damage anti-inflammatory macrophages that preserve the enteric neurons.